An Expert View on a growing trend among drug developers from Rik Van Mol, vice president of R&D strategy, Europe, Veeva Systems.
A majority of life sciences companies are taking action to unify clinical processes to improve trial performance, according to a survey. Results from the Veeva 2018 Unified Clinical Operations Survey reveal that nearly all (99%) clinical leaders acknowledge the need to unify their clinical operating environments, and most (87%) have plans in place to get there. Here’s what we learned:
Need for better visibility and faster trial execution
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze